Prospective evaluation of 18F-FACBC PET/CT and PET/MRI versus multiparametric MRI in intermediate- to high-risk prostate cancer patients (FLUCIPRO trial)




Jambor I, Kuisma A, Kähkönen E, Kemppainen J, Merisaari H, Eskola O, Teuho J, Perez IM, Pesola M, Aronen HJ, Boström PJ, Taimen P, Minn H

PublisherSpringer Berlin Heidelberg

2018

European Journal of Nuclear Medicine and Molecular Imaging

European Journal of Nuclear Medicine and Molecular Imaging

45

3

355

364

10

1619-7070

DOIhttps://doi.org/10.1007/s00259-017-3875-1



Conclusions

Quantitative 18F-FACBC imaging significantly correlated with GS but failed to outperform MRI in lesion detection. 18F-FACBC may assist in targeted biopsies in the setting of hybrid imaging with MRI.



Last updated on 2024-26-11 at 12:17